Clinical Interventions and Hemodynamic Monitoring in the Setting of Left Ventricular Systolic Heart Failure in Children: Insights From a Physiologic Simulator.

IF 2.9 4区 医学 Q2 PHARMACOLOGY & PHARMACY American journal of therapeutics Pub Date : 2024-09-01 DOI:10.1097/MJT.0000000000001711
Rohit S Loomba, Fabio Savorgnan, Sebastian Acosta, Justin J Elhoff, Juan S Farias, Enrique G Villarreal, Saul Flores
{"title":"Clinical Interventions and Hemodynamic Monitoring in the Setting of Left Ventricular Systolic Heart Failure in Children: Insights From a Physiologic Simulator.","authors":"Rohit S Loomba, Fabio Savorgnan, Sebastian Acosta, Justin J Elhoff, Juan S Farias, Enrique G Villarreal, Saul Flores","doi":"10.1097/MJT.0000000000001711","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In pediatric critical care, vasoactive/inotropic support is widely used in patients with heart failure, but it remains controversial because the influence of multiple medications and the interplay between their inotropic and vasoactive effects on a given patient are hard to predict. Robust evidence supporting their use and quantifying their effects in this group of patients is scarce.</p><p><strong>Study question: </strong>The aim of this study was to characterize the effect of vasoactive medications on various cardiovascular parameters in pediatric patient with decreased ejection fraction.</p><p><strong>Study design: </strong>Clinical-data based physiologic simulator study.</p><p><strong>Measure and outcomes: </strong>We used a physics-based computer simulator for quantifying the response of cardiovascular parameters to the administration of various types of vasoactive/inotropic medications in pediatric patients with decreased ejection fraction. The simulator allowed us to study the impact of increasing medication dosage and the simultaneous administration of some vasoactive agents. Correlation and linear regression analyses yielded the quantified effects on the vasoactive/inotropic support.</p><p><strong>Results: </strong>Cardiac output and systemic venous saturation significantly increased with the administration of dobutamine and milrinone in isolation, and combination of milrinone with dobutamine, dopamine, or epinephrine. Both parameters decreased with the administration of epinephrine and norepinephrine in isolation. No significant change in these hemodynamic parameters was observed with the administration of dopamine in isolation.</p><p><strong>Conclusions: </strong>Milrinone and dobutamine were the only vasoactive medications that, when used in isolation, improved systemic oxygen delivery. Milrinone in combination with dobutamine, dopamine, or epinephrine also increased systemic oxygen delivery. The induced increment on afterload can negatively affect systemic oxygen delivery.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 5","pages":"e531-e540"},"PeriodicalIF":2.9000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MJT.0000000000001711","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In pediatric critical care, vasoactive/inotropic support is widely used in patients with heart failure, but it remains controversial because the influence of multiple medications and the interplay between their inotropic and vasoactive effects on a given patient are hard to predict. Robust evidence supporting their use and quantifying their effects in this group of patients is scarce.

Study question: The aim of this study was to characterize the effect of vasoactive medications on various cardiovascular parameters in pediatric patient with decreased ejection fraction.

Study design: Clinical-data based physiologic simulator study.

Measure and outcomes: We used a physics-based computer simulator for quantifying the response of cardiovascular parameters to the administration of various types of vasoactive/inotropic medications in pediatric patients with decreased ejection fraction. The simulator allowed us to study the impact of increasing medication dosage and the simultaneous administration of some vasoactive agents. Correlation and linear regression analyses yielded the quantified effects on the vasoactive/inotropic support.

Results: Cardiac output and systemic venous saturation significantly increased with the administration of dobutamine and milrinone in isolation, and combination of milrinone with dobutamine, dopamine, or epinephrine. Both parameters decreased with the administration of epinephrine and norepinephrine in isolation. No significant change in these hemodynamic parameters was observed with the administration of dopamine in isolation.

Conclusions: Milrinone and dobutamine were the only vasoactive medications that, when used in isolation, improved systemic oxygen delivery. Milrinone in combination with dobutamine, dopamine, or epinephrine also increased systemic oxygen delivery. The induced increment on afterload can negatively affect systemic oxygen delivery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿童左心室收缩性心力衰竭的临床干预和血流动力学监测:生理模拟器的启示。
背景:在儿科重症监护中,血管活性/肌力支持被广泛应用于心力衰竭患者,但由于很难预测多种药物的影响及其对特定患者肌力和血管活性效应之间的相互作用,因此仍存在争议。支持在这类患者中使用这些药物并量化其效果的有力证据十分稀少:本研究旨在确定血管活性药物对射血分数降低的儿科患者各种心血管参数的影响:研究设计:基于临床数据的生理模拟器研究:我们使用基于物理的计算机模拟器,量化射血分数下降的儿科患者在服用各种类型的血管活性药物/肌注药物后心血管参数的反应。通过模拟器,我们可以研究增加药物剂量和同时使用某些血管活性药物的影响。相关性和线性回归分析得出了对血管活性/肌力支持的量化影响:结果:单独使用多巴酚丁胺和米力农,以及米力农与多巴酚丁胺、多巴胺或肾上腺素联合使用时,心输出量和全身静脉饱和度明显增加。单独使用肾上腺素和去甲肾上腺素时,这两个参数都会降低。在单独使用多巴胺时,这些血流动力学参数没有明显变化:结论:米力农和多巴酚丁胺是单独使用时唯一能改善全身氧输送的血管活性药物。米力农与多巴酚丁胺、多巴胺或肾上腺素联合使用也能增加全身供氧量。诱导的后负荷增加会对全身供氧量产生负面影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American journal of therapeutics
American journal of therapeutics PHARMACOLOGY & PHARMACY-
CiteScore
5.50
自引率
9.50%
发文量
142
审稿时长
6-12 weeks
期刊介绍: American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.
期刊最新文献
Aficamten Versus Placebo in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis. Evaluating Donanemab: Advances and Challenges in Alzheimer Disease Treatment. Mirikizumab for Chronic Plaque Psoriasis: A Systematic Review and Meta-Analysis. Safety and Effectiveness Comparison of Epidural Block and Quadratus Lumborum Block in Patients Undergoing Renal and Urological Surgery: A Systematic Review and Meta-Analysis. Safety and Efficacy of Seladelpar in Treatment of Patients With Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1